Agevisa/PB Takes Action to Combat Smoking in Paraiba Region

Sep.01.2022
Agevisa/PB Takes Action to Combat Smoking in Paraiba Region
Brazil's Agevisa reinforces actions against smoking in Paraíba and emphasizes partnerships for health protection and environmental sustainability.

The Brazilian National Health Surveillance Agency (Agevisa) has been strengthening its actions and partnerships aimed at combating smoking in the Paraiba region throughout the year. On August 29th (National Day to Combat Tobacco), General Director Geraldo Moreira de Menezes outlined measures that not only aim to educate the public about the serious harm caused by tobacco products but also to train collaborating organizations to better protect human health and the state's environment.


He emphasized the importance of establishing partnerships between the State Health Surveillance Agency, Procon/PB, the Public Department, state and federal police, Sudema/PB, the Federal Revenue Service, and other state health agencies (members of this structure). This Agency has been providing advice on the implementation and execution of a quality management system for Agevisa/PB, which has yielded very positive results. The improvement of this Agency's activities in promoting and protecting human health in Paraíba has been positively impacted.


From August 22 to 25, Agevisa/PB actively participated in a training program on tobacco control legislation and inspection for health supervisors and Procons professionals in Paraiba. The event was held online and was co-organized by the National Cancer Institute (Inca), the National Health Surveillance Agency (Anvisa), and the Pan American Health Organization (PAHO).


Helena Teixeira de Lima Barbosa, the Technical Director of Agevisa/PB's Medical Science and Technology and Related department, discussed the role of health monitoring in tobacco control. She focused on the responsibilities and challenges facing regulators and highlighted the importance of societal awareness and participation in the fight against smoking. In her speech, Helena discussed Paraiba's health surveillance actions, responsibilities, legal documents, and experiences in combating smoking. She emphasized the extreme damage to health and the environment caused by the many substances in tobacco products, including electronic cigarette devices, also known as e-cigarettes.


According to Geraldo Moreira, this year Agevisa/PB has also promoted tobacco product inspection training for coordinators and municipal health inspectors to expand and improve the promotion and protection of public health in the region.


On June 14th and 15th, training was held for public health surveillance professionals in National Health Zones 1, 12, and 14. On March 30th, a training session was conducted for Visas staff from various cities in the second health zone during an event in Guarabira/PB.


Sustainability and tobacco control - Agevisa/PB is also actively involved in the National Cancer Institute's technical visit program to Paraiba to introduce sustainable tobacco control projects. From June 27th to July 1st, 2022, representatives from INCA, PAHO, the Secretary of State, and the Municipal Health Secretary discussed the project, Agevisa/PB, Empresa Paraibana de Turismo (PBTur), and tourism in the capital of Paraiba at the Casa de Jose Americo Foundation in João Pessoa/PB.


Geraldo Moreira de Menezes, the director general of Agevisa/PB, attended the event and emphasized the state government's commitment to expanding efforts to combat smoking in Paraiba. He discussed the agency's responsibility for oversight and education, and pointed out their concerns about the growth of smoking, including hookah and e-cigarettes.


Confiscation of electronic cigarettes - as part of a permanent effort to combat smoking in Paraiba, the director of Agevisa/PB emphasized on the 29th that the working group, which was launched on June 30th in João Pessoa/PB, seized a large number of electronic smoking devices at a tobacco store near Tambau. The owner of the establishment was arrested at the time and taken to the Federal Police Headquarters for questioning.


Késsia Liliana, the head of Procon/PB, Hugo José de Barros Franca, the health technology director, and Ado Augusto Bezerra de Brito, the health risk inspection and control technology manager from Agevisa attended this operation. PB, Procon inspectors, and federal police agent Geraldo Moreira announced an intensified inspection and imposed sanitary penalties on those responsible for public or private collective-use environments allowing the use of electronic cigarettes, vaporizers, vapes, and e-cigarettes throughout the state of Paraiba. The use of cigarettes, electronic cigarettes, e-cigarettes, or any other electronic smoking device (DEF) is prohibited in environments under their responsibility.


According to Geraldo Moreira, the initiative of Law 12,351/2022 aims to strengthen Paraiba's struggle against smoking by creating a smoke-free environment for collective use, considering whether Law 1 originated from smoke.


Disclaimer: 1. The content of this article is compiled from third-party information and is only for industry exchange and learning purposes. 2. This article does not represent the views of 2FIRSTS, and 2FIRSTS is also unable to confirm the truthfulness and accuracy of the content. The compile of this article is only for industry exchange and research purposes. 3. Due to the limited compilation level, the compiled article may not express the same meaning as the original, please refer to the original article for accuracy. 4. Regarding any domestic, Hong Kong, Macao, Taiwan, and foreign expressions and positions, 2FIRSTS maintains full consistency with the Chinese government. 5. The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

France Bans Zyn and Other Nicotine Pouches, Violators Face Jail and Fines
France Bans Zyn and Other Nicotine Pouches, Violators Face Jail and Fines
France has officially banned nicotine pouches and other oral nicotine products, including Zyn. The new regulation classifies such products as “toxic substances” and imposes criminal penalties on their use, possession, purchase, and sale. Violators may face up to five years in prison and fines of up to €400,000 (approximately $436,600).
Regulations
May.25
One Year After UK Disposable Vape Ban: Youth Use Falls to 13%, Adult Use to 8%
One Year After UK Disposable Vape Ban: Youth Use Falls to 13%, Adult Use to 8%
among both youth and adults. However, industry groups and regulators warn that the illicit vape market remains a growing concern.
Jun.09
Illicit Vape and Nicotine Pouch Seizures Concentrated in UK Hotspots, New Data Shows
Illicit Vape and Nicotine Pouch Seizures Concentrated in UK Hotspots, New Data Shows
Freedom of Information (FOI) data from the UK shows that more than 3,000 seizures of illegal nicotine products were recorded in the 2024/25 financial year, with Hull, Liverpool and Bolton emerging as the most active enforcement hotspots — highlighting that the problem of illicit vapes, nicotine pouches and smokeless tobacco products persists across many parts of the country.
Jun.16
Nicotine Pouches Lead U.S. Tobacco Growth as Vape Sales Decline
Nicotine Pouches Lead U.S. Tobacco Growth as Vape Sales Decline
New convenience store industry data show nicotine pouches have become the primary growth driver in the tobacco category, with oral nicotine sales rising nearly 30% over the past year while vape sales declined.
Business
Jun.05
Ispire Reports Fiscal Q3 2026 Revenue of $18.7 Million and Net Loss of $9.5 Million
Ispire Reports Fiscal Q3 2026 Revenue of $18.7 Million and Net Loss of $9.5 Million
Ispire Technology reported financial results on May 7, 2026, for the third quarter of fiscal 2026, covering the three months ended March 31, 2026. Revenue was $18.7 million, compared with $26.2 million in the third quarter of fiscal 2025 and $20.3 million in the prior quarter. Gross profit was $2.0 million, with gross margin of 10.7%. Net loss was $9.5 million, or $0.17 per share. The company said it held $18.0 million in cash as of March 31, 2026, up $468,000 sequentially.
May.08 by 2FIRSTS.ai
Tobacco Farming in the New Nicotine Era: Why Indian Farmers Struggle to Transition — Contributed by Samrat Chowdhery
Tobacco Farming in the New Nicotine Era: Why Indian Farmers Struggle to Transition — Contributed by Samrat Chowdhery
In this contributed article to 2Firsts, Mumbai-based journalist and harm reduction advocate Samrat Chowdhery examines India’s tobacco transition from the perspective of agriculture, supply chains and regulation. As noted by 2Firsts, India offers a relevant case for understanding how new nicotine technologies may affect not only consumption, trade and policy, but also tobacco farming.
Special Report
May.29